|
|
Volumn 18, Issue 9, 2000, Pages 1809-1811
|
|
Oligonucleotide therapeutics: A step forward
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
COMPLEMENTARY RNA;
MESSENGER RNA;
OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;
PROTEIN BCL 2;
SINGLE STRANDED DNA;
CANCER GENETICS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
EDITORIAL;
GENE EXPRESSION REGULATION;
GENE TARGETING;
GENE THERAPY;
HUMAN;
NONHODGKIN LYMPHOMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN SYNTHESIS INHIBITION;
|
|
EID: 0034015778
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2000.18.9.1809 Document Type: Editorial |
|
Times cited : (46)
|
|
References (38)
|
